» Authors » Michael Hausding

Michael Hausding

Explore the profile of Michael Hausding including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 1425
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Steven S, Oelze M, Hausding M, Roohani S, Kashani F, Kroller-Schon S, et al.
Oxid Med Cell Longev . 2019 Jan; 2018:7845629. PMID: 30687454
Objective: Organic nitrates such as isosorbide-5-mononitrate (ISMN) and isosorbide dinitrate (ISDN) are used for the treatment of patients with chronic symptomatic stable coronary artery disease and chronic congestive heart failure....
2.
Steven S, Dib M, Hausding M, Kashani F, Oelze M, Kroller-Schon S, et al.
Cardiovasc Res . 2017 Oct; 114(2):312-323. PMID: 29036612
Aims: CD40 ligand (CD40L) signaling controls vascular oxidative stress and related dysfunction in angiotensin-II-induced arterial hypertension by regulating vascular immune cell recruitment and platelet activation. Here we investigated the role...
3.
Wang X, Hausding M, Weng S, Kim Y, Steven S, Klein T, et al.
Antioxid Redox Signal . 2017 Jun; 28(2):87-109. PMID: 28635324
Aims: Nonalcoholic steatohepatitis (NASH) is characterized by steatosis, panlobular inflammation, liver fibrosis, and increased cardiovascular mortality. Dipeptidyl peptidase-4 inhibitors (gliptins) are indirect glucagon-like peptide 1 agonists with antidiabetic and anti-inflammatory...
4.
Stein J, Steven S, Bros M, Sudowe S, Hausding M, Oelze M, et al.
Oxid Med Cell Longev . 2017 May; 2017:4157213. PMID: 28458776
. Activation/maturation of dendritic cells (DCs) plays a central role in adaptive immune responses by antigen processing and (cross-) activation of T cells. There is ongoing discussion on the role...
5.
Steven S, Hausding M, Kroller-Schon S, Mader M, Mikhed Y, Stamm P, et al.
Basic Res Cardiol . 2015 Jan; 110(2):6. PMID: 25600227
Dipeptidyl peptidase (DPP)-4 inhibitors are used to treat hyperglycemia by increasing the incretin glucagon-like peptide-1 (GLP-1). Previous studies showed anti-inflammatory and antiatherosclerotic effects of DPP-4 inhibitors. Here, we compared the...
6.
Oelze M, Kroller-Schon S, Welschof P, Jansen T, Hausding M, Mikhed Y, et al.
PLoS One . 2014 Nov; 9(11):e112394. PMID: 25402275
Objective: In diabetes, vascular dysfunction is characterized by impaired endothelial function due to increased oxidative stress. Empagliflozin, as a selective sodium-glucose co-transporter 2 inhibitor (SGLT2i), offers a novel approach for...
7.
Knorr M, Hausding M, Pfeffer A, Jurk K, Jansen T, Schwierczek K, et al.
Pharmacology . 2014 Jun; 93(5-6):203-15. PMID: 24923291
Background/aims: Organic nitrates represent a group of nitrovasodilators that are clinically used for the treatment of ischemic heart disease. The new compound CLC-3000 is an aminoethyl nitrate (AEN) derivative of...
8.
Oelze M, Kroller-Schon S, Steven S, Lubos E, Doppler C, Hausding M, et al.
Hypertension . 2013 Dec; 63(2):390-6. PMID: 24296279
Recently, we demonstrated that gene ablation of mitochondrial manganese superoxide dismutase and aldehyde dehydrogenase-2 markedly contributed to age-related vascular dysfunction and mitochondrial oxidative stress. The present study has sought to...
9.
Hausding M, Jurk K, Daub S, Kroller-Schon S, Stein J, Schwenk M, et al.
Basic Res Cardiol . 2013 Sep; 108(6):386. PMID: 24061433
CD40 ligand (CD40L) is involved in the vascular infiltration of immune cells and pathogenesis of atherosclerosis. Additionally, T cell CD40L release causes platelet, dendritic cell and monocyte activation in thrombosis....
10.
Kroller-Schon S, Steven S, Kossmann S, Scholz A, Daub S, Oelze M, et al.
Antioxid Redox Signal . 2013 Jul; 20(2):247-66. PMID: 23845067
Aims: Oxidative stress is involved in the development of cardiovascular disease. There is a growing body of evidence for a crosstalk between different enzymatic sources of oxidative stress. With the...